Aug 4 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX :
* GOT FINAL REPORT FROM PRECLINICAL STUDY OF LEAD COMPOUND EMTINB IN AN IN VITRO MULTIPLE SCLEROSIS (MS) MODEL
Aug 4 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX :
* GOT FINAL REPORT FROM PRECLINICAL STUDY OF LEAD COMPOUND EMTINB IN AN IN VITRO MULTIPLE SCLEROSIS (MS) MODEL